Ensysce Biosciences logo

Ensysce Biosciences

ENSC | NASDAQ
Chart Builder DCF Calculator
$0.47
-$0.04 (-8.02%)
At close: Oct 23, 2026, 4:00 PM ET
-8.02%

Rating

Updated: Oct 10, 2026
41.5
+10.0 pts
Fundamentals Average
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $9.15M
1D Range
0.47 0.52
52W Range
0.23 2.26

Valuation (TTM)

PE -0.19
PB -11.71
EV/EBITDA -0.69

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Loading financial charts...

Profile

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the Unit...

Sector Healthcare
Industry Biotechnology
Employees 7
IPO Date Mar 14, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.